Bay Area scientists explain why the delta variant is ‘COVID on steroids’

By the time June 15 rolled around and San Francisco and the rest of California emerged from the prolonged pandemic lockdown, Peter Johnston was fully vaccinated and ready to have one of the best summers of his life.

He hit bars and clubs in the Castro every Friday and Saturday, and a few weeknights in between. He rented a house in Carmel with some friends, then took a trip up to Guerneville with another group. “It was definitely a Roaring Twenties kind of thing,” said Johnston, 29, who said he found himself relating to the celebrations that followed the end of the 1918-19 pandemic and World War I.

But the party came to an abrupt halt two weeks ago, when Johnston woke up one Monday feeling ill. He developed a bad cough, then fever and chills and body aches. He tested positive for the coronavirus a week later.

“I would definitely say I thought the pandemic was over, or at least firmly in the rearview mirror,” Johnston said from his home in the Castro, where he’s still recuperating. “I knew there was a possibility of getting COVID after being vaccinated, but I didn’t think it would happen to me.”

Evidence is growing that post-vaccination breakthrough cases like Johnston’s are not as rare as once previously thought, or perhaps hoped for. And the culprit appears to be the highly infectious delta variant that’s now dominating San Francisco and pretty much everywhere else in the United States.

To be clear: The vaccines are holding up when it comes to preventing the most dire outcomes, in particular hospitalization, intensive care requiring ventilation, and death. They’re also still very good at preventing infection. Vaccines remain the best protection against COVID-19 and are key to ending the pandemic.

Peter Johnston, who lives in San Francisco’s Castro district, became infected with the delta variant after being fully vaccinated for COVID-19. “I knew there was a possibility of getting COVID after being vaccinated, but I didn’t think it would happen to me.”

Nick Otto/Special to The Chronicle

But delta is proving to be the first variant to test the strength of the vaccines, especially when it comes to stopping transmission. And that, in turn, has led to disheartening setbacks in the public health response as cases rise faster now that at any other time in the pandemic and health officials consider new mask mandates and other measures to stop the spread of disease.

“It is COVID on steroids. In many ways this is a different virus than the virus we were dealing with earlier this year,” said Dr. Grant Colfax, director of the San Francisco Department of Public Health, in a news briefing on Friday during which he implored people who are not vaccinated to get the shots now.

Experts in vaccines and immunology say the breakthrough infections, though disappointing, are not unexpected and do not mean the COVID vaccines are failing. Indeed, studies of post-vaccination cases, and better data on why they may be happening, underscore that the vaccine-induced immune response is robust and multi-layered.

Mounting evidence suggests that delta is so easily transmissible in large part because it replicates much faster than previous variants and exposes people to a much higher viral load.

That larger viral dose may be overwhelming the first-strike antibody response in vaccinated people, who were better able to shake off earlier variants and remain symptom free. It may also mean that they are infectious and able to spread the virus to others, perhaps as easily as those who are not vaccinated — an especially discouraging finding, health experts said.

But antibodies aren’t the only tool of the immune system to fend off the coronavirus. And so far it appears that the next-level response — namely the T cells and B cells that wipe out virus that’s able to evade antibodies — is doing its job well and preventing severe illness.

“The vaccines have maintained full protection against severe and critical illness, even with delta,” said Dr. Catherine Blish, an infectious disease expert at Stanford. “Most of these (post-vaccination) cases we’re seeing are mild or sometimes moderate illness, and that means the vaccine is giving people a head start in clearing the virus but it’s not quite enough to prevent the infection in the first place. But at least it’s keeping them out of the hospital.”



Read original article here

Leave a Comment